Goldenwell Financial Statements From 2010 to 2025

GWLL Stock  USD 2.95  0.05  1.67%   
Goldenwell Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Goldenwell Biotech's valuation are provided below:
Goldenwell Biotech does not presently have any fundamental trends for analysis.
Check Goldenwell Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Goldenwell Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Goldenwell financial statements analysis is a perfect complement when working with Goldenwell Biotech Valuation or Volatility modules.
  
This module can also supplement various Goldenwell Biotech Technical models . Check out the analysis of Goldenwell Biotech Correlation against competitors.

Goldenwell Biotech Company Operating Margin Analysis

Goldenwell Biotech's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Goldenwell Biotech Operating Margin

    
  (568.00) %  
Most of Goldenwell Biotech's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Goldenwell Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Goldenwell Biotech has an Operating Margin of -568.0%. This is much higher than that of the Consumer Defensive sector and notably lower than that of the Packaged Foods industry. The operating margin for all United States stocks is notably higher than that of the company.

Goldenwell Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Goldenwell Biotech's current stock value. Our valuation model uses many indicators to compare Goldenwell Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Goldenwell Biotech competition to find correlations between indicators driving Goldenwell Biotech's intrinsic value. More Info.
Goldenwell Biotech is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Goldenwell Biotech's earnings, one of the primary drivers of an investment's value.

About Goldenwell Biotech Financial Statements

Goldenwell Biotech investors utilize fundamental indicators, such as revenue or net income, to predict how Goldenwell Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company was incorporated in 2019 and is based in Twinsburg, Ohio. Goldenwell Biotech is traded on OTC Exchange in the United States.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

Other Information on Investing in Goldenwell Pink Sheet

Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.